MX373056B - Formas cristalinas de glecaprevir. - Google Patents
Formas cristalinas de glecaprevir.Info
- Publication number
- MX373056B MX373056B MX2016016127A MX2016016127A MX373056B MX 373056 B MX373056 B MX 373056B MX 2016016127 A MX2016016127 A MX 2016016127A MX 2016016127 A MX2016016127 A MX 2016016127A MX 373056 B MX373056 B MX 373056B
- Authority
- MX
- Mexico
- Prior art keywords
- crystalline forms
- glecaprevir
- compound
- crystalline
- figures
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462008786P | 2014-06-06 | 2014-06-06 | |
| PCT/US2015/034371 WO2015188045A1 (en) | 2014-06-06 | 2015-06-05 | Crystal forms |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2016016127A MX2016016127A (es) | 2017-02-23 |
| MX373056B true MX373056B (es) | 2020-05-20 |
Family
ID=54767417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016016127A MX373056B (es) | 2014-06-06 | 2015-06-05 | Formas cristalinas de glecaprevir. |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US9321807B2 (enExample) |
| EP (2) | EP4403223B1 (enExample) |
| JP (4) | JP2017518319A (enExample) |
| CN (1) | CN106413736A (enExample) |
| AU (2) | AU2015269306B2 (enExample) |
| CA (1) | CA2948902C (enExample) |
| DK (1) | DK4403223T3 (enExample) |
| ES (1) | ES3075172T3 (enExample) |
| FI (1) | FI4403223T3 (enExample) |
| MX (1) | MX373056B (enExample) |
| PT (1) | PT4403223T (enExample) |
| RS (1) | RS68261B1 (enExample) |
| WO (1) | WO2015188045A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015188045A1 (en) * | 2014-06-06 | 2015-12-10 | Abbvie Inc. | Crystal forms |
| WO2021137256A1 (en) | 2020-01-03 | 2021-07-08 | Mylan Laboratories Limited | Polymorphic forms of glecaprevir |
| GB202113944D0 (en) * | 2021-09-29 | 2021-11-10 | Univ Liverpool | Injectable formulations |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5604234A (en) | 1991-09-05 | 1997-02-18 | Abbott Laboratories | Substituted thiol macrolactam immunomodulators |
| UY28240A1 (es) * | 2003-03-27 | 2004-11-08 | Boehringer Ingelheim Pharma | Fases cristalinas de un potente inhibidor de la hcv |
| KR100995390B1 (ko) * | 2006-01-02 | 2010-11-19 | 주식회사 삼양제넥스 | 무정형, 무수결정형 또는 수화 결정형 도세탁셀의 제조방법 |
| ES2392611T3 (es) * | 2008-07-22 | 2012-12-12 | Merck Sharp & Dohme Corp. | Compuestos de quinoxalina macrocíclica como inhibidores de la proteasa NS3 del VHC |
| EP2470189A4 (en) * | 2009-08-27 | 2013-01-23 | Merck Sharp & Dohme | METHOD FOR PRODUCING PROTEASE INHIBITORS OF HEPATITIS C VIRUS |
| TWI523658B (zh) | 2010-09-21 | 2016-03-01 | 安塔製藥公司 | 巨環脯胺酸衍生之ｈｃｖ絲胺酸蛋白酶抑制劑 |
| MX2014001945A (es) * | 2011-08-19 | 2014-03-27 | Merck Sharp & Dohme | Procedimiento e intermedios para la preparacion de macrolactamas. |
| MX2015000535A (es) * | 2012-07-12 | 2015-05-11 | Abbvie Inc | Formas cristalinas de un inhibidor de vhc. |
| CN105658219A (zh) * | 2013-10-25 | 2016-06-08 | 艾伯维公司 | 用于治疗hcv的方法 |
| WO2015188045A1 (en) * | 2014-06-06 | 2015-12-10 | Abbvie Inc. | Crystal forms |
-
2015
- 2015-06-05 WO PCT/US2015/034371 patent/WO2015188045A1/en not_active Ceased
- 2015-06-05 CN CN201580029787.7A patent/CN106413736A/zh active Pending
- 2015-06-05 PT PT241519347T patent/PT4403223T/pt unknown
- 2015-06-05 US US14/731,765 patent/US9321807B2/en active Active
- 2015-06-05 EP EP24151934.7A patent/EP4403223B1/en active Active
- 2015-06-05 JP JP2016571301A patent/JP2017518319A/ja active Pending
- 2015-06-05 AU AU2015269306A patent/AU2015269306B2/en active Active
- 2015-06-05 DK DK24151934.7T patent/DK4403223T3/da active
- 2015-06-05 MX MX2016016127A patent/MX373056B/es active IP Right Grant
- 2015-06-05 FI FIEP24151934.7T patent/FI4403223T3/fi active
- 2015-06-05 EP EP15803592.3A patent/EP3151850A4/en not_active Withdrawn
- 2015-06-05 ES ES24151934T patent/ES3075172T3/es active Active
- 2015-06-05 CA CA2948902A patent/CA2948902C/en active Active
- 2015-06-05 RS RS20260777A patent/RS68261B1/en unknown
-
2016
- 2016-04-11 US US15/095,474 patent/US9561181B2/en active Active
-
2020
- 2020-09-23 AU AU2020239679A patent/AU2020239679A1/en not_active Abandoned
-
2021
- 2021-03-23 JP JP2021048244A patent/JP2021113192A/ja active Pending
-
2023
- 2023-04-12 JP JP2023064709A patent/JP2023089125A/ja active Pending
-
2024
- 2024-10-15 JP JP2024179614A patent/JP2025004239A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US9561181B2 (en) | 2017-02-07 |
| US20150353600A1 (en) | 2015-12-10 |
| US9321807B2 (en) | 2016-04-26 |
| WO2015188045A1 (en) | 2015-12-10 |
| EP3151850A1 (en) | 2017-04-12 |
| DK4403223T3 (da) | 2026-06-29 |
| JP2021113192A (ja) | 2021-08-05 |
| EP3151850A4 (en) | 2017-11-29 |
| AU2015269306B2 (en) | 2020-06-25 |
| PT4403223T (pt) | 2026-07-17 |
| FI4403223T3 (fi) | 2026-07-13 |
| ES3075172T3 (en) | 2026-07-28 |
| EP4403223B1 (en) | 2026-05-13 |
| MX2016016127A (es) | 2017-02-23 |
| EP4403223A2 (en) | 2024-07-24 |
| JP2023089125A (ja) | 2023-06-27 |
| AU2020239679A1 (en) | 2020-10-15 |
| JP2025004239A (ja) | 2025-01-14 |
| AU2015269306A1 (en) | 2016-12-22 |
| CN106413736A (zh) | 2017-02-15 |
| RS68261B1 (en) | 2026-07-31 |
| JP2017518319A (ja) | 2017-07-06 |
| CA2948902A1 (en) | 2015-12-10 |
| EP4403223A3 (en) | 2024-10-09 |
| CA2948902C (en) | 2022-11-22 |
| US20160220487A1 (en) | 2016-08-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3713931C0 (en) | 3-OXO-6-HETEROARYL-2-PHENYL-2,3-DIHYDROPYRIDAZINE-4-CARBOXAMIDE | |
| DK3253762T3 (da) | 9h-pyrrolo-dipyridinderivater. | |
| CL2015000430S1 (es) | Alumbrado exterior. | |
| EP3246440A4 (en) | Knitted lace | |
| EP3663026A4 (en) | Lathe | |
| BR112017013156A2 (pt) | combinações de composto ativo. | |
| BR112017018633A2 (pt) | tintas brancas. | |
| IT201600084952A1 (it) | Coglifrutta. | |
| BR112017012801A2 (pt) | combinações de composto ativo. | |
| ES1150114Y (es) | Abarcón. | |
| HRP20180585T1 (hr) | Spojevi 2,7-diazaspiro[3.5]nonana | |
| ES2789757T8 (es) | Herramienta de conformado | |
| LT3253749T (lt) | Junginiai, pasižymintys priešnavikiniu aktyvumu | |
| LT3233862T (lt) | Imidazopiridazino dariniai, kaip pi3kbeta slopikliai | |
| ITUB20152270A1 (it) | Macchina lava-asciuga pavimenti. | |
| CL2015002617S1 (es) | Motocicleta. | |
| BR112016018071A2 (pt) | composição de larvicida. | |
| CL2014002529S1 (es) | Alumbrado exterior. | |
| EP4403223A3 (en) | Crystal forms | |
| MX2020006006A (es) | Polimorfos cristalinos de {(2s,3r)-1-[(2s)-2-{5-[(2r,5r)-1-{3,5-di fluoro-4-[4-(4-fluorofenil)piperidin-1-il]fenil}-5-(6-fluoro-2-{( 2s)-1-[n-(metoxicarbonil)-o-metil-l-treonil]pirrolidin-2-il}-1h-b enzimidazol-5-il)pirrolidin-2-il]-6-fluoro-1h-benzimidazol-2-il}p irrolidin-1-il]-3-metoxi-1-oxobutan-2-il}carbamato de metilo. | |
| ITUB20161122A1 (it) | Seminatrice. | |
| ITUB20160244A1 (it) | Macchina utensile. | |
| ES1124406Y (es) | Pieza de hormigón luminiscente. | |
| GB2557192B (en) | Semiconductor patterning | |
| GB2556313B (en) | Semiconductor patterning |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |